- Home
- DT vs FMS Comparison
DT vs FMS Comparison
Compare DT & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DT
- FMS
- Stock Information
- Founded
- DT 2005
- FMS 1996
- Country
- DT United States
- FMS Germany
- Employees
- DT N/A
- FMS N/A
- Industry
- DT Computer Software: Prepackaged Software
- FMS Misc Health and Biotechnology Services
- Sector
- DT Technology
- FMS Health Care
- Exchange
- DT Nasdaq
- FMS Nasdaq
- Market Cap
- DT 15.2B
- FMS 14.1B
- IPO Year
- DT 2019
- FMS 1996
- Fundamental
- Price
- DT $46.75
- FMS $23.40
- Analyst Decision
- DT Buy
- FMS Sell
- Analyst Count
- DT 22
- FMS 2
- Target Price
- DT $62.14
- FMS $30.00
- AVG Volume (30 Days)
- DT 3.8M
- FMS 486.5K
- Earning Date
- DT 11-05-2025
- FMS 11-04-2025
- Dividend Yield
- DT N/A
- FMS 2.44%
- EPS Growth
- DT 208.33
- FMS 8.40
- EPS
- DT 1.66
- FMS 2.86
- Revenue
- DT $1,852,532,000.00
- FMS $23,046,819,198.00
- Revenue This Year
- DT $20.09
- FMS $1.75
- Revenue Next Year
- DT $14.56
- FMS $3.01
- P/E Ratio
- DT $28.14
- FMS $16.08
- Revenue Growth
- DT 18.50
- FMS 2.10
- 52 Week Low
- DT $39.30
- FMS $21.32
- 52 Week High
- DT $63.00
- FMS $30.46
- Technical
- Relative Strength Index (RSI)
- DT 41.04
- FMS 26.24
- Support Level
- DT $45.84
- FMS $23.61
- Resistance Level
- DT $47.60
- FMS $24.17
- Average True Range (ATR)
- DT 1.63
- FMS 0.40
- MACD
- DT -0.27
- FMS -0.29
- Stochastic Oscillator
- DT 26.22
- FMS 0.79
About DT Dynatrace Inc.
Dynatrace is a software-as-a-service company that enables customers to monitor and analyze their information technology infrastructure, from servers to applications and Python scripts. Dynatrace's unified platform can ingest and analyze large amounts of machine-generated data in real time, allowing clients to optimize their business for service-level objectives and ensure uptime.
About FMS Fresenius Medical Care AG
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.